Application 208630

Type
NDA
Sponsor
NXDC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GLEOLANAMINOLEVULINIC ACID HYDROCHLORIDEFOR SOLUTION;ORAL1.5GM/VIALYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
59137-231GLEOLANAMINOLEVULINIC ACID HYDROCHLORIDEMedexus Pharma, Inc.NDACurrent
71469-231GLEOLANAMINOLEVULINIC ACID HYDROCHLORIDENX DEVELOPMENT CORPNDACurrent
71469-231GLEOLANAMINOLEVULINIC ACID HYDROCHLORIDENX DEVELOPMENT CORPNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
78237SUPPL 2024-04-24
78233SUPPL 2024-04-24
58045SUPPL2019-03-20
55314SUPPL2018-08-24
55277SUPPL2018-08-23
55135ORIG2018-08-08
54663SUPPL2018-06-21
54600SUPPL2018-06-14
48663ORIG2017-06-07
48662ORIG2017-06-07